Drawing for SENSIPHI

USPTO serial 79146712

SENSIPHI

Reviewed by CopyMark Law Group

Reg. 4714429Status 739Registered
Filing date
Status date
Registration date
Apr 7, 2015
Examiner
HUSSAIN, TASNEEM
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with SENSIPHI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel M. Gurfinkel

Daniel M. Gurfinkel Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemical solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular chemical reagents, enzymes and chemical solutions in the nature of buffer solutions for nucleic acid amplification; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid amplificationACTIVE
005Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; kits containing preparations for medical and veterinary diagnostic purposes, primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplificationACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 30, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 30, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 18, 2025ES75TEAS SECTION 71 & 15 RECEIVED
Apr 7, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jan 4, 2024RNWLINTERNATIONAL REGISTRATION RENEWED
Jun 16, 2021NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 16, 2021C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 16, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 18, 2021ES75TEAS SECTION 71 & 15 RECEIVED
Apr 7, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 18, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 4, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Aug 14, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 14, 2015FIMPFINAL DISPOSITION PROCESSED
Jul 7, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 7, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 20, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 20, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 15, 2015GPNXNOTIFICATION PROCESSED BY IB
Dec 31, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 31, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 31, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 13, 2014ALIEASSIGNED TO LIE
Dec 2, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 22, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2014RFNTREFUSAL PROCESSED BY IB
May 22, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 22, 2014RFRRREFUSAL PROCESSED BY MPU
May 21, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 20, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2014MAFRAPPLICATION FILING RECEIPT MAILED
May 16, 2014DOCKASSIGNED TO EXAMINER
May 16, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance